APO Research
Talk to an analyst

APO RESEARCH · REPORT

Brain and Central Nervous System Cancer Treatments

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Brain and Central Nervous System Cancer Treatments Industry Growth and Trends Forecast to 2032

28 December 2025123 pages

Choose your research edition.

Industry ResearchBrain and Central Nervous System Cancer Treatments Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Brain and Central Nervous System Cancer Treatments Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Brain and Central Nervous System Cancer Treatments Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Brain and Central Nervous System Cancer Treatments Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Brain and Central Nervous System Cancer Treatments Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Brain and Central Nervous System Cancer Treatments market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Brain and Central Nervous System Cancer Treatments is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Brain and Central Nervous System Cancer Treatments is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Brain and Central Nervous System Cancer Treatments is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Brain and Central Nervous System Cancer Treatments include Teva, Sanofi, Johnson & Johnson, Novartis, Merck & Co., Roche, Pfizer, Bayer and AbbVie, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Brain and Central Nervous System Cancer Treatments market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Brain and Central Nervous System Cancer Treatments market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Brain and Central Nervous System Cancer Treatments market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Brain and Central Nervous System Cancer Treatments.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Brain and Central Nervous System Cancer Treatments market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Brain and Central Nervous System Cancer Treatments Market by Company

Teva

Sanofi

Johnson & Johnson

Novartis

Merck & Co.

Roche

Pfizer

Bayer

AbbVie

Takeda

Otsuka

Merck KGaA

Ipsen

Gilead Sciences

Eli Lilly

Eisai

Celgene

Bristol-Myers Squibb

Biogen Idec

AstraZeneca

Astellas

Amgen

Brain and Central Nervous System Cancer Treatments Segment by Type

Immunotherapy (Biologic Therapy)

Hormonal Therapy

Chemotherapy

Targeted Therapy

Others

Brain and Central Nervous System Cancer Treatments Segment by Application

Brain Cancer

Spinal Cord Cancer

Others

Brain and Central Nervous System Cancer Treatments Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brain and Central Nervous System Cancer Treatments market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Brain and Central Nervous System Cancer Treatments and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brain and Central Nervous System Cancer Treatments.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Brain and Central Nervous System Cancer Treatments manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Brain and Central Nervous System Cancer Treatments in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Immunotherapy (Biologic Therapy) Table 2. Major Company of Hormonal Therapy Table 3. Major Company of Chemotherapy Table 4. Major Company of Targeted Therapy Table 5. Major Company of Others Table 6. Global Brain and Central Nervous System Cancer Treatments Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026) & (K Units) Table 8. Global Brain and Central Nervous System Cancer Treatments Sales Market Share in Volume by Type (2021-2026) Table 9. Global Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026) & (US$ Million) Table 10. Global Brain and Central Nervous System Cancer Treatments Sales Market Share in Value by Type (2021-2026) Table 11. Global Brain and Central Nervous System Cancer Treatments Price by Type (2021-2026) & (US$/Unit) Table 12. Global Brain and Central Nervous System Cancer Treatments Sales by Type (2027-2032) & (K Units) Table 13. Global Brain and Central Nervous System Cancer Treatments Sales Market Share in Volume by Type (2027-2032) Table 14. Global Brain and Central Nervous System Cancer Treatments Sales by Type (2027-2032) & (US$ Million) Table 15. Global Brain and Central Nervous System Cancer Treatments Sales Market Share in Value by Type (2027-2032) Table 16. Global Brain and Central Nervous System Cancer Treatments Price by Type (2027-2032) & (US$/Unit) Table 17. North America Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026) & (K Units) Table 18. North America Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026) & (K Units) Table 20. Europe Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026) & (K Units) Table 24. Latin America Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026) & (US$ Million) Table 27. Brain and Central Nervous System Cancer Treatments Industry Trends Table 28. Brain and Central Nervous System Cancer Treatments Industry Drivers Table 29. Brain and Central Nervous System Cancer Treatments Industry Opportunities and Challenges Table 30. Brain and Central Nervous System Cancer Treatments Industry Restraints Table 31. Global Brain and Central Nervous System Cancer Treatments Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Company (2021-2026) Table 33. Global Brain and Central Nervous System Cancer Treatments Sales by Company (2021-2026) & (K Units) Table 34. Global Brain and Central Nervous System Cancer Treatments Sales Share by Company (2021-2026) Table 35. Global Brain and Central Nervous System Cancer Treatments Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Brain and Central Nervous System Cancer Treatments Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Brain and Central Nervous System Cancer Treatments Major Company Production Sites and Headquarters Table 38. Global Brain and Central Nervous System Cancer Treatments Company, Product Type & Application Table 39. Global Brain and Central Nervous System Cancer Treatments Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Brain and Central Nervous System Cancer Treatments by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Brain and Central Nervous System Cancer Treatments Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Brain and Central Nervous System Cancer Treatments Sales by Region (2021-2026) & (K Units) Table 44. Global Brain and Central Nervous System Cancer Treatments Sales Market Share in Volume by Region (2021-2026) Table 45. Global Brain and Central Nervous System Cancer Treatments Sales by Region (2021-2026) & (US$ Million) Table 46. Global Brain and Central Nervous System Cancer Treatments Sales Market Share in Value by Region (2021-2026) Table 47. Global Brain and Central Nervous System Cancer Treatments Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Brain and Central Nervous System Cancer Treatments Sales by Region (2027-2032) & (K Units) Table 49. Global Brain and Central Nervous System Cancer Treatments Sales Market Share in Volume by Region (2027-2032) Table 50. Global Brain and Central Nervous System Cancer Treatments Sales by Region (2027-2032) & (US$ Million) Table 51. Global Brain and Central Nervous System Cancer Treatments Sales Market Share in Value by Region (2027-2032) Table 52. Global Brain and Central Nervous System Cancer Treatments Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Brain and Central Nervous System Cancer Treatments Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026) & (K Units) Table 55. Global Brain and Central Nervous System Cancer Treatments Sales Market Share in Volume by Application (2021-2026) Table 56. Global Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026) & (US$ Million) Table 57. Global Brain and Central Nervous System Cancer Treatments Sales Market Share in Value by Application (2021-2026) Table 58. Global Brain and Central Nervous System Cancer Treatments Price by Application (2021-2026) & (US$/Unit) Table 59. Global Brain and Central Nervous System Cancer Treatments Sales by Application (2027-2032) & (K Units) Table 60. Global Brain and Central Nervous System Cancer Treatments Sales Market Share in Volume by Application (2027-2032) Table 61. Global Brain and Central Nervous System Cancer Treatments Sales by Application (2027-2032) & (US$ Million) Table 62. Global Brain and Central Nervous System Cancer Treatments Sales Market Share in Value by Application (2027-2032) Table 63. Global Brain and Central Nervous System Cancer Treatments Price by Application (2027-2032) & (US$/Unit) Table 64. North America Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026) & (K Units) Table 65. North America Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026) & (K Units) Table 67. Europe Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026) & (K Units) Table 71. Latin America Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026) & (US$ Million) Table 74. Teva Company Information Table 75. Teva Business Overview Table 76. Teva Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Teva Brain and Central Nervous System Cancer Treatments Product Portfolio Table 78. Teva Recent Development Table 79. Sanofi Company Information Table 80. Sanofi Business Overview Table 81. Sanofi Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Sanofi Brain and Central Nervous System Cancer Treatments Product Portfolio Table 83. Sanofi Recent Development Table 84. Johnson & Johnson Company Information Table 85. Johnson & Johnson Business Overview Table 86. Johnson & Johnson Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Johnson & Johnson Brain and Central Nervous System Cancer Treatments Product Portfolio Table 88. Johnson & Johnson Recent Development Table 89. Novartis Company Information Table 90. Novartis Business Overview Table 91. Novartis Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Novartis Brain and Central Nervous System Cancer Treatments Product Portfolio Table 93. Novartis Recent Development Table 94. Merck & Co. Company Information Table 95. Merck & Co. Business Overview Table 96. Merck & Co. Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Merck & Co. Brain and Central Nervous System Cancer Treatments Product Portfolio Table 98. Merck & Co. Recent Development Table 99. Roche Company Information Table 100. Roche Business Overview Table 101. Roche Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Roche Brain and Central Nervous System Cancer Treatments Product Portfolio Table 103. Roche Recent Development Table 104. Pfizer Company Information Table 105. Pfizer Business Overview Table 106. Pfizer Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Pfizer Brain and Central Nervous System Cancer Treatments Product Portfolio Table 108. Pfizer Recent Development Table 109. Bayer Company Information Table 110. Bayer Business Overview Table 111. Bayer Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Bayer Brain and Central Nervous System Cancer Treatments Product Portfolio Table 113. Bayer Recent Development Table 114. AbbVie Company Information Table 115. AbbVie Business Overview Table 116. AbbVie Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. AbbVie Brain and Central Nervous System Cancer Treatments Product Portfolio Table 118. AbbVie Recent Development Table 119. Takeda Company Information Table 120. Takeda Business Overview Table 121. Takeda Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Takeda Brain and Central Nervous System Cancer Treatments Product Portfolio Table 123. Takeda Recent Development Table 124. Otsuka Company Information Table 125. Otsuka Business Overview Table 126. Otsuka Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Otsuka Brain and Central Nervous System Cancer Treatments Product Portfolio Table 128. Otsuka Recent Development Table 129. Merck KGaA Company Information Table 130. Merck KGaA Business Overview Table 131. Merck KGaA Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Merck KGaA Brain and Central Nervous System Cancer Treatments Product Portfolio Table 133. Merck KGaA Recent Development Table 134. Ipsen Company Information Table 135. Ipsen Business Overview Table 136. Ipsen Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Ipsen Brain and Central Nervous System Cancer Treatments Product Portfolio Table 138. Ipsen Recent Development Table 139. Gilead Sciences Company Information Table 140. Gilead Sciences Business Overview Table 141. Gilead Sciences Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Gilead Sciences Brain and Central Nervous System Cancer Treatments Product Portfolio Table 143. Gilead Sciences Recent Development Table 144. Eli Lilly Company Information Table 145. Eli Lilly Business Overview Table 146. Eli Lilly Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Eli Lilly Brain and Central Nervous System Cancer Treatments Product Portfolio Table 148. Eli Lilly Recent Development Table 149. Eisai Company Information Table 150. Eisai Business Overview Table 151. Eisai Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Eisai Brain and Central Nervous System Cancer Treatments Product Portfolio Table 153. Eisai Recent Development Table 154. Celgene Company Information Table 155. Celgene Business Overview Table 156. Celgene Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Celgene Brain and Central Nervous System Cancer Treatments Product Portfolio Table 158. Celgene Recent Development Table 159. Bristol-Myers Squibb Company Information Table 160. Bristol-Myers Squibb Business Overview Table 161. Bristol-Myers Squibb Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. Bristol-Myers Squibb Brain and Central Nervous System Cancer Treatments Product Portfolio Table 163. Bristol-Myers Squibb Recent Development Table 164. Biogen Idec Company Information Table 165. Biogen Idec Business Overview Table 166. Biogen Idec Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 167. Biogen Idec Brain and Central Nervous System Cancer Treatments Product Portfolio Table 168. Biogen Idec Recent Development Table 169. AstraZeneca Company Information Table 170. AstraZeneca Business Overview Table 171. AstraZeneca Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 172. AstraZeneca Brain and Central Nervous System Cancer Treatments Product Portfolio Table 173. AstraZeneca Recent Development Table 174. Astellas Company Information Table 175. Astellas Business Overview Table 176. Astellas Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 177. Astellas Brain and Central Nervous System Cancer Treatments Product Portfolio Table 178. Astellas Recent Development Table 179. Amgen Company Information Table 180. Amgen Business Overview Table 181. Amgen Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 182. Amgen Brain and Central Nervous System Cancer Treatments Product Portfolio Table 183. Amgen Recent Development Table 184. North America Brain and Central Nervous System Cancer Treatments Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 185. North America Brain and Central Nervous System Cancer Treatments Sales by Country (2021-2026) & (K Units) Table 186. North America Brain and Central Nervous System Cancer Treatments Sales Market Share by Country (2021-2026) Table 187. North America Brain and Central Nervous System Cancer Treatments Sales Forecast by Country (2027-2032) & (K Units) Table 188. North America Brain and Central Nervous System Cancer Treatments Sales Market Share Forecast by Country (2027-2032) Table 189. North America Brain and Central Nervous System Cancer Treatments Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 190. North America Brain and Central Nervous System Cancer Treatments Market Size by Country (2021-2026) & (US$ Million) Table 191. North America Brain and Central Nervous System Cancer Treatments Market Share by Country (2021-2026) Table 192. North America Brain and Central Nervous System Cancer Treatments Market Size Forecast by Country (2027-2032) & (US$ Million) Table 193. North America Brain and Central Nervous System Cancer Treatments Market Share Forecast by Country (2027-2032) Table 194. Europe Brain and Central Nervous System Cancer Treatments Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 195. Europe Brain and Central Nervous System Cancer Treatments Sales by Country (2021-2026) & (K Units) Table 196. Europe Brain and Central Nervous System Cancer Treatments Sales Market Share by Country (2021-2026) Table 197. Europe Brain and Central Nervous System Cancer Treatments Sales Forecast by Country (2027-2032) & (K Units) Table 198. Europe Brain and Central Nervous System Cancer Treatments Sales Market Share Forecast by Country (2027-2032) Table 199. Europe Brain and Central Nervous System Cancer Treatments Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 200. Europe Brain and Central Nervous System Cancer Treatments Market Size by Country (2021-2026) & (US$ Million) Table 201. Europe Brain and Central Nervous System Cancer Treatments Market Share by Country (2021-2026) Table 202. Europe Brain and Central Nervous System Cancer Treatments Market Size Forecast by Country (2027-2032) & (US$ Million) Table 203. Europe Brain and Central Nervous System Cancer Treatments Market Share Forecast by Country (2027-2032) Table 204. Asia-Pacific Brain and Central Nervous System Cancer Treatments Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 205. Asia-Pacific Brain and Central Nervous System Cancer Treatments Sales by Country (2021-2026) & (K Units) Table 206. Asia-Pacific Brain and Central Nervous System Cancer Treatments Sales Market Share by Country (2021-2026) Table 207. Asia-Pacific Brain and Central Nervous System Cancer Treatments Sales Forecast by Country (2027-2032) & (K Units) Table 208. Asia-Pacific Brain and Central Nervous System Cancer Treatments Sales Market Share Forecast by Country (2027-2032) Table 209. Asia-Pacific Brain and Central Nervous System Cancer Treatments Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 210. Asia-Pacific Brain and Central Nervous System Cancer Treatments Market Size by Country (2021-2026) & (US$ Million) Table 211. Asia-Pacific Brain and Central Nervous System Cancer Treatments Market Share by Country (2021-2026) Table 212. Asia-Pacific Brain and Central Nervous System Cancer Treatments Market Size Forecast by Country (2027-2032) & (US$ Million) Table 213. Asia-Pacific Brain and Central Nervous System Cancer Treatments Market Share Forecast by Country (2027-2032) Table 214. Latin America Brain and Central Nervous System Cancer Treatments Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 215. Latin America Brain and Central Nervous System Cancer Treatments Sales by Country (2021-2026) & (K Units) Table 216. Latin America Brain and Central Nervous System Cancer Treatments Sales Market Share by Country (2021-2026) Table 217. Latin America Brain and Central Nervous System Cancer Treatments Sales Forecast by Country (2027-2032) & (K Units) Table 218. Latin America Brain and Central Nervous System Cancer Treatments Sales Market Share Forecast by Country (2027-2032) Table 219. Latin America Brain and Central Nervous System Cancer Treatments Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 220. Latin America Brain and Central Nervous System Cancer Treatments Market Size by Country (2021-2026) & (US$ Million) Table 221. Latin America Brain and Central Nervous System Cancer Treatments Market Share by Country (2021-2026) Table 222. Latin America Brain and Central Nervous System Cancer Treatments Market Size Forecast by Country (2027-2032) & (US$ Million) Table 223. Latin America Brain and Central Nervous System Cancer Treatments Market Share Forecast by Country (2027-2032) Table 224. Middle East and Africa Brain and Central Nervous System Cancer Treatments Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 225. Middle East and Africa Brain and Central Nervous System Cancer Treatments Sales by Country (2021-2026) & (K Units) Table 226. Middle East and Africa Brain and Central Nervous System Cancer Treatments Sales Market Share by Country (2021-2026) Table 227. Middle East and Africa Brain and Central Nervous System Cancer Treatments Sales Forecast by Country (2027-2032) & (K Units) Table 228. Middle East and Africa Brain and Central Nervous System Cancer Treatments Sales Market Share Forecast by Country (2027-2032) Table 229. Middle East and Africa Brain and Central Nervous System Cancer Treatments Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 230. Middle East and Africa Brain and Central Nervous System Cancer Treatments Market Size by Country (2021-2026) & (US$ Million) Table 231. Middle East and Africa Brain and Central Nervous System Cancer Treatments Market Share by Country (2021-2026) Table 232. Middle East and Africa Brain and Central Nervous System Cancer Treatments Market Size Forecast by Country (2027-2032) & (US$ Million) Table 233. Middle East and Africa Brain and Central Nervous System Cancer Treatments Market Share Forecast by Country (2027-2032) Table 234. Key Raw Materials Table 235. Raw Materials Key Suppliers Table 236. Brain and Central Nervous System Cancer Treatments Distributors List Table 237. Brain and Central Nervous System Cancer Treatments Customers List Table 238. Research Programs/Design for This Report Table 239. Authors List of This Report Table 240. Secondary Sources Table 241. Primary Sources List of Figures Figure 1. Brain and Central Nervous System Cancer Treatments Image Figure 2. Global Brain and Central Nervous System Cancer Treatments Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Brain and Central Nervous System Cancer Treatments Market Size (2021-2032) & (US$ Million) Figure 4. Global Brain and Central Nervous System Cancer Treatments Sales (2021-2032) & (K Units) Figure 5. Immunotherapy (Biologic Therapy) Image Figure 6. Global Immunotherapy (Biologic Therapy) Sales YoY Growth (2021-2032) & (K Units) Figure 7. Hormonal Therapy Image Figure 8. Global Hormonal Therapy Sales YoY Growth (2021-2032) & (K Units) Figure 9. Chemotherapy Image Figure 10. Global Chemotherapy Sales YoY Growth (2021-2032) & (K Units) Figure 11. Targeted Therapy Image Figure 12. Global Targeted Therapy Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Brain and Central Nervous System Cancer Treatments Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Brain and Central Nervous System Cancer Treatments Market Share by Type 2025 VS 2032 Figure 17. North America Brain and Central Nervous System Cancer Treatments Sales Market Share in Volume by Type in 2025 Figure 18. North America Brain and Central Nervous System Cancer Treatments Sales Market Share in Value by Type in 2025 Figure 19. Europe Brain and Central Nervous System Cancer Treatments Sales Market Share in Volume by Type in 2025 Figure 20. Europe Brain and Central Nervous System Cancer Treatments Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Brain and Central Nervous System Cancer Treatments Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Brain and Central Nervous System Cancer Treatments Sales Market Share in Value by Type in 2025 Figure 23. Latin America Brain and Central Nervous System Cancer Treatments Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Brain and Central Nervous System Cancer Treatments Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Brain and Central Nervous System Cancer Treatments Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Brain and Central Nervous System Cancer Treatments Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Brain and Central Nervous System Cancer Treatments Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Brain Cancer Image Figure 30. Global Brain Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 31. Spinal Cord Cancer Image Figure 32. Global Spinal Cord Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Brain and Central Nervous System Cancer Treatments Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Brain and Central Nervous System Cancer Treatments Market Share by Application 2025 VS 2032 Figure 37. North America Brain and Central Nervous System Cancer Treatments Sales Market Share in Volume by Application in 2025 Figure 38. North America Brain and Central Nervous System Cancer Treatments Sales Market Share in Value by Application in 2025 Figure 39. Europe Brain and Central Nervous System Cancer Treatments Sales Market Share in Volume by Application in 2025 Figure 40. Europe Brain and Central Nervous System Cancer Treatments Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Brain and Central Nervous System Cancer Treatments Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Brain and Central Nervous System Cancer Treatments Sales Market Share in Value by Application in 2025 Figure 43. Latin America Brain and Central Nervous System Cancer Treatments Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Brain and Central Nervous System Cancer Treatments Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Brain and Central Nervous System Cancer Treatments Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Brain and Central Nervous System Cancer Treatments Sales Market Share in Value by Application in 2025 Figure 47. North America Brain and Central Nervous System Cancer Treatments Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Brain and Central Nervous System Cancer Treatments Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Brain and Central Nervous System Cancer Treatments Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Brain and Central Nervous System Cancer Treatments Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Brain and Central Nervous System Cancer Treatments Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Brain and Central Nervous System Cancer Treatments Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Brain and Central Nervous System Cancer Treatments Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Brain and Central Nervous System Cancer Treatments Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Brain and Central Nervous System Cancer Treatments Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Brain and Central Nervous System Cancer Treatments Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Brain and Central Nervous System Cancer Treatments Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Brain and Central Nervous System Cancer Treatments Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Brain and Central Nervous System Cancer Treatments Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Brain and Central Nervous System Cancer Treatments Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Brain and Central Nervous System Cancer Treatments Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Brain and Central Nervous System Cancer Treatments Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Brain and Central Nervous System Cancer Treatments Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Brain and Central Nervous System Cancer Treatments Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Brain and Central Nervous System Cancer Treatments Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Brain and Central Nervous System Cancer Treatments Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Brain and Central Nervous System Cancer Treatments Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Brain and Central Nervous System Cancer Treatments Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Immunotherapy (Biologic Therapy)
  • Hormonal Therapy
  • Chemotherapy
  • Targeted Therapy
  • Others
Applications
  • Brain Cancer
  • Spinal Cord Cancer
  • Others
Companies covered
  • Teva
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck & Co.
  • Roche
  • Pfizer
  • Bayer
  • AbbVie
  • Takeda
  • Otsuka
  • Merck KGaA
  • Ipsen
  • Gilead Sciences
  • Eli Lilly
  • Eisai
  • Celgene
  • Bristol-Myers Squibb
  • Biogen Idec
  • AstraZeneca
  • Astellas
  • Amgen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Brain and Central Nervous System Cancer Treatments Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Brain and Central Nervous System Cancer Treatments Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Brain and Central Nervous System Cancer Treatments Market by Type
  6. 1.3.1 Immunotherapy (Biologic Therapy)
  7. 1.3.2 Hormonal Therapy
  8. 1.3.3 Chemotherapy
  9. 1.3.4 Targeted Therapy
  10. 1.3.5 Others
  11. 1.4 Global Brain and Central Nervous System Cancer Treatments Market Size by Type
  12. 1.4.1 Global Brain and Central Nervous System Cancer Treatments Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Brain and Central Nervous System Cancer Treatments Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Brain and Central Nervous System Cancer Treatments Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Brain and Central Nervous System Cancer Treatments Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Brain and Central Nervous System Cancer Treatments Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Brain and Central Nervous System Cancer Treatments Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Brain and Central Nervous System Cancer Treatments Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Brain and Central Nervous System Cancer Treatments Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Brain and Central Nervous System Cancer Treatments Industry Trends
  2. 2.2 Brain and Central Nervous System Cancer Treatments Industry Drivers
  3. 2.3 Brain and Central Nervous System Cancer Treatments Industry Opportunities and Challenges
  4. 2.4 Brain and Central Nervous System Cancer Treatments Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Brain and Central Nervous System Cancer Treatments Revenue (2021-2026)
  2. 3.2 Global Top Players by Brain and Central Nervous System Cancer Treatments Sales (2021-2026)
  3. 3.3 Global Top Players by Brain and Central Nervous System Cancer Treatments Price (2021-2026)
  4. 3.4 Global Brain and Central Nervous System Cancer Treatments Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Brain and Central Nervous System Cancer Treatments Major Company Production Sites & Headquarters
  6. 3.6 Global Brain and Central Nervous System Cancer Treatments Company, Product Type & Application
  7. 3.7 Global Brain and Central Nervous System Cancer Treatments Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Brain and Central Nervous System Cancer Treatments Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Brain and Central Nervous System Cancer Treatments Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Brain and Central Nervous System Cancer Treatments Tier 1, Tier 2, and Tier 3
4 Brain and Central Nervous System Cancer Treatments Regional Status and Outlook
  1. 4.1 Global Brain and Central Nervous System Cancer Treatments Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Brain and Central Nervous System Cancer Treatments Historic Market Size by Region
  3. 4.2.1 Global Brain and Central Nervous System Cancer Treatments Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Brain and Central Nervous System Cancer Treatments Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Brain and Central Nervous System Cancer Treatments Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Brain and Central Nervous System Cancer Treatments Forecasted Market Size by Region
  7. 4.3.1 Global Brain and Central Nervous System Cancer Treatments Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Brain and Central Nervous System Cancer Treatments Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Brain and Central Nervous System Cancer Treatments Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Brain and Central Nervous System Cancer Treatments by Application
  1. 5.1 Brain and Central Nervous System Cancer Treatments Market by Application
  2. 5.1.1 Brain Cancer
  3. 5.1.2 Spinal Cord Cancer
  4. 5.1.3 Others
  5. 5.2 Global Brain and Central Nervous System Cancer Treatments Market Size by Application
  6. 5.2.1 Global Brain and Central Nervous System Cancer Treatments Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Brain and Central Nervous System Cancer Treatments Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Brain and Central Nervous System Cancer Treatments Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Brain and Central Nervous System Cancer Treatments Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Brain and Central Nervous System Cancer Treatments Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Brain and Central Nervous System Cancer Treatments Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Brain and Central Nervous System Cancer Treatments Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Brain and Central Nervous System Cancer Treatments Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Brain and Central Nervous System Cancer Treatments Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Brain and Central Nervous System Cancer Treatments Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Brain and Central Nervous System Cancer Treatments Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Brain and Central Nervous System Cancer Treatments Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Johnson & Johnson
  14. 6.3.1 Johnson & Johnson Company Information
  15. 6.3.2 Johnson & Johnson Business Overview
  16. 6.3.3 Johnson & Johnson Brain and Central Nervous System Cancer Treatments Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Johnson & Johnson Brain and Central Nervous System Cancer Treatments Product Portfolio
  18. 6.3.5 Johnson & Johnson Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Brain and Central Nervous System Cancer Treatments Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Brain and Central Nervous System Cancer Treatments Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Merck & Co.
  26. 6.5.1 Merck & Co. Company Information
  27. 6.5.2 Merck & Co. Business Overview
  28. 6.5.3 Merck & Co. Brain and Central Nervous System Cancer Treatments Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Merck & Co. Brain and Central Nervous System Cancer Treatments Product Portfolio
  30. 6.5.5 Merck & Co. Recent Developments
  31. 6.6 Roche
  32. 6.6.1 Roche Company Information
  33. 6.6.2 Roche Business Overview
  34. 6.6.3 Roche Brain and Central Nervous System Cancer Treatments Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Roche Brain and Central Nervous System Cancer Treatments Product Portfolio
  36. 6.6.5 Roche Recent Developments
  37. 6.7 Pfizer
  38. 6.7.1 Pfizer Company Information
  39. 6.7.2 Pfizer Business Overview
  40. 6.7.3 Pfizer Brain and Central Nervous System Cancer Treatments Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer Brain and Central Nervous System Cancer Treatments Product Portfolio
  42. 6.7.5 Pfizer Recent Developments
  43. 6.8 Bayer
  44. 6.8.1 Bayer Company Information
  45. 6.8.2 Bayer Business Overview
  46. 6.8.3 Bayer Brain and Central Nervous System Cancer Treatments Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bayer Brain and Central Nervous System Cancer Treatments Product Portfolio
  48. 6.8.5 Bayer Recent Developments
  49. 6.9 AbbVie
  50. 6.9.1 AbbVie Company Information
  51. 6.9.2 AbbVie Business Overview
  52. 6.9.3 AbbVie Brain and Central Nervous System Cancer Treatments Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 AbbVie Brain and Central Nervous System Cancer Treatments Product Portfolio
  54. 6.9.5 AbbVie Recent Developments
  55. 6.10 Takeda
  56. 6.10.1 Takeda Company Information
  57. 6.10.2 Takeda Business Overview
  58. 6.10.3 Takeda Brain and Central Nervous System Cancer Treatments Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Takeda Brain and Central Nervous System Cancer Treatments Product Portfolio
  60. 6.10.5 Takeda Recent Developments
  61. 6.11 Otsuka
  62. 6.11.1 Otsuka Company Information
  63. 6.11.2 Otsuka Business Overview
  64. 6.11.3 Otsuka Brain and Central Nervous System Cancer Treatments Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Otsuka Brain and Central Nervous System Cancer Treatments Product Portfolio
  66. 6.11.5 Otsuka Recent Developments
  67. 6.12 Merck KGaA
  68. 6.12.1 Merck KGaA Company Information
  69. 6.12.2 Merck KGaA Business Overview
  70. 6.12.3 Merck KGaA Brain and Central Nervous System Cancer Treatments Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Merck KGaA Brain and Central Nervous System Cancer Treatments Product Portfolio
  72. 6.12.5 Merck KGaA Recent Developments
  73. 6.13 Ipsen
  74. 6.13.1 Ipsen Company Information
  75. 6.13.2 Ipsen Business Overview
  76. 6.13.3 Ipsen Brain and Central Nervous System Cancer Treatments Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Ipsen Brain and Central Nervous System Cancer Treatments Product Portfolio
  78. 6.13.5 Ipsen Recent Developments
  79. 6.14 Gilead Sciences
  80. 6.14.1 Gilead Sciences Company Information
  81. 6.14.2 Gilead Sciences Business Overview
  82. 6.14.3 Gilead Sciences Brain and Central Nervous System Cancer Treatments Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Gilead Sciences Brain and Central Nervous System Cancer Treatments Product Portfolio
  84. 6.14.5 Gilead Sciences Recent Developments
  85. 6.15 Eli Lilly
  86. 6.15.1 Eli Lilly Company Information
  87. 6.15.2 Eli Lilly Business Overview
  88. 6.15.3 Eli Lilly Brain and Central Nervous System Cancer Treatments Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Eli Lilly Brain and Central Nervous System Cancer Treatments Product Portfolio
  90. 6.15.5 Eli Lilly Recent Developments
  91. 6.16 Eisai
  92. 6.16.1 Eisai Company Information
  93. 6.16.2 Eisai Business Overview
  94. 6.16.3 Eisai Brain and Central Nervous System Cancer Treatments Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Eisai Brain and Central Nervous System Cancer Treatments Product Portfolio
  96. 6.16.5 Eisai Recent Developments
  97. 6.17 Celgene
  98. 6.17.1 Celgene Company Information
  99. 6.17.2 Celgene Business Overview
  100. 6.17.3 Celgene Brain and Central Nervous System Cancer Treatments Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Celgene Brain and Central Nervous System Cancer Treatments Product Portfolio
  102. 6.17.5 Celgene Recent Developments
  103. 6.18 Bristol-Myers Squibb
  104. 6.18.1 Bristol-Myers Squibb Company Information
  105. 6.18.2 Bristol-Myers Squibb Business Overview
  106. 6.18.3 Bristol-Myers Squibb Brain and Central Nervous System Cancer Treatments Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Bristol-Myers Squibb Brain and Central Nervous System Cancer Treatments Product Portfolio
  108. 6.18.5 Bristol-Myers Squibb Recent Developments
  109. 6.19 Biogen Idec
  110. 6.19.1 Biogen Idec Company Information
  111. 6.19.2 Biogen Idec Business Overview
  112. 6.19.3 Biogen Idec Brain and Central Nervous System Cancer Treatments Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Biogen Idec Brain and Central Nervous System Cancer Treatments Product Portfolio
  114. 6.19.5 Biogen Idec Recent Developments
  115. 6.20 AstraZeneca
  116. 6.20.1 AstraZeneca Company Information
  117. 6.20.2 AstraZeneca Business Overview
  118. 6.20.3 AstraZeneca Brain and Central Nervous System Cancer Treatments Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 AstraZeneca Brain and Central Nervous System Cancer Treatments Product Portfolio
  120. 6.20.5 AstraZeneca Recent Developments
  121. 6.21 Astellas
  122. 6.21.1 Astellas Company Information
  123. 6.21.2 Astellas Business Overview
  124. 6.21.3 Astellas Brain and Central Nervous System Cancer Treatments Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Astellas Brain and Central Nervous System Cancer Treatments Product Portfolio
  126. 6.21.5 Astellas Recent Developments
  127. 6.22 Amgen
  128. 6.22.1 Amgen Company Information
  129. 6.22.2 Amgen Business Overview
  130. 6.22.3 Amgen Brain and Central Nervous System Cancer Treatments Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Amgen Brain and Central Nervous System Cancer Treatments Product Portfolio
  132. 6.22.5 Amgen Recent Developments
7 North America by Country
  1. 7.1 North America Brain and Central Nervous System Cancer Treatments Sales by Country
  2. 7.1.1 North America Brain and Central Nervous System Cancer Treatments Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Brain and Central Nervous System Cancer Treatments Sales by Country (2021-2026)
  4. 7.1.3 North America Brain and Central Nervous System Cancer Treatments Sales Forecast by Country (2027-2032)
  5. 7.2 North America Brain and Central Nervous System Cancer Treatments Market Size by Country
  6. 7.2.1 North America Brain and Central Nervous System Cancer Treatments Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Brain and Central Nervous System Cancer Treatments Market Size by Country (2021-2026)
  8. 7.2.3 North America Brain and Central Nervous System Cancer Treatments Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Brain and Central Nervous System Cancer Treatments Sales by Country
  2. 8.1.1 Europe Brain and Central Nervous System Cancer Treatments Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Brain and Central Nervous System Cancer Treatments Sales by Country (2021-2026)
  4. 8.1.3 Europe Brain and Central Nervous System Cancer Treatments Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Brain and Central Nervous System Cancer Treatments Market Size by Country
  6. 8.2.1 Europe Brain and Central Nervous System Cancer Treatments Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Brain and Central Nervous System Cancer Treatments Market Size by Country (2021-2026)
  8. 8.2.3 Europe Brain and Central Nervous System Cancer Treatments Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Brain and Central Nervous System Cancer Treatments Sales by Country
  2. 9.1.1 Asia-Pacific Brain and Central Nervous System Cancer Treatments Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Brain and Central Nervous System Cancer Treatments Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Brain and Central Nervous System Cancer Treatments Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Brain and Central Nervous System Cancer Treatments Market Size by Country
  6. 9.2.1 Asia-Pacific Brain and Central Nervous System Cancer Treatments Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Brain and Central Nervous System Cancer Treatments Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Brain and Central Nervous System Cancer Treatments Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Brain and Central Nervous System Cancer Treatments Sales by Country
  2. 10.1.1 South America Brain and Central Nervous System Cancer Treatments Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Brain and Central Nervous System Cancer Treatments Sales by Country (2021-2026)
  4. 10.1.3 South America Brain and Central Nervous System Cancer Treatments Sales Forecast by Country (2027-2032)
  5. 10.2 South America Brain and Central Nervous System Cancer Treatments Market Size by Country
  6. 10.2.1 South America Brain and Central Nervous System Cancer Treatments Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Brain and Central Nervous System Cancer Treatments Market Size by Country (2021-2026)
  8. 10.2.3 South America Brain and Central Nervous System Cancer Treatments Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Brain and Central Nervous System Cancer Treatments Sales by Country
  2. 11.1.1 Middle East and Africa Brain and Central Nervous System Cancer Treatments Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Brain and Central Nervous System Cancer Treatments Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Brain and Central Nervous System Cancer Treatments Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Brain and Central Nervous System Cancer Treatments Market Size by Country
  6. 11.2.1 Middle East and Africa Brain and Central Nervous System Cancer Treatments Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Brain and Central Nervous System Cancer Treatments Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Brain and Central Nervous System Cancer Treatments Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Brain and Central Nervous System Cancer Treatments Value Chain Analysis
  2. 12.1.1 Brain and Central Nervous System Cancer Treatments Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Brain and Central Nervous System Cancer Treatments Production Mode & Process
  7. 12.2 Brain and Central Nervous System Cancer Treatments Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Brain and Central Nervous System Cancer Treatments Distributors
  10. 12.2.3 Brain and Central Nervous System Cancer Treatments Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst